Conference
Topoisomerase II alpha protein overexpression has predictive utility in a randomized trial comparing CMF to CEF in premenopausal women with node positive breast cancer (NCIC CTG MA.5).
Authors
O'Malley FP; Chia S; Tu D; Shepherd LE; Levine MN; Huntsman D; Bramwell VH; Andrulis I; Pritchard K
Volume
100
Pagination
pp. S18-S18
Publisher
SPRINGER
Publication Date
January 1, 2006
Name of conference
29th Annual San Antonio Breast Cancer Symposium
Conference place
San Antonio, TX
Conference start date
December 14, 2006
Conference end date
December 17, 2006
Conference proceedings
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806